Support our online development, and advance our onground research initiatives in free market economics, as we seek to showcase the brightest Next-Gen minds.
THE ME-P DISCLAIMER: Posts, comments and opinions do not necessarily represent iMBA, Inc., but become our property after submission. Copyright © 2006 to-date. iMBA, Inc allows colleges, universities, medical and financial professionals and related clinics, hospitals and non-profit healthcare organizations to distribute our proprietary essays, photos, videos, audios and other documents; etc. However, please review copyright and usage information for each individual asset before submission to us, and/or placement on your publication or web site. Attestation references, citations and/or back-links are required. All other assets are property of the individual copyright holder.
BY KFF
Prescription drug costs are a major concern for consumers and a fiscal challenge for public and private payers, representing 10% of national health spending and nearly 20% of health benefit costs for large employers and Medicare.
In response, lawmakers are considering a broad range of policy options, including one that would allow the federal government to negotiate prescription drug prices on behalf of Medicare beneficiaries and people enrolled in private plans, a proposal that has strong bipartisan public support.
CITE: https://www.r2library.com/Resource/Title/0826102549
****
This brief describes the current status of drug price negotiation proposals, looks back at the history of proposals to give the federal government the authority to negotiate drug prices in Medicare, describes the negotiation provisions in key legislation (H.R. 3), and discusses the potential spending effects for the federal government and individuals.
READ: https://www.kff.org/medicare/issue-brief/whats-the-latest-on-medicare-drug-price-negotiations/
YOUR THOUGHTS AND COMMENTS ARE APPRECIATED.
Thank You
***
****
Share this:
Filed under: Drugs and Pharma, Glossary Terms, Health Economics, Health Insurance, Health Law & Policy, Healthcare Finance | Tagged: KFF, medicare, Medicare Drug Price Negotiations? |
The Leading Business Education Network for Doctors, Financial Advisors and Health Industry Consultants 
Medicare at 60?
However, there will likely be pushback from health care providers. When a patient uses Medicare, the health care providers are typically compensated at a lower rate. Health care providers also have less flexibility to negotiate their prices under Medicare, compared to private or employer-based health insurance
https://www.msn.com/en-us/money/retirement/democrats-push-bill-to-lower-medicare-eligibility-age-to-60/ar-AAOoHVi?li=BBnb7Kz
Jeff
LikeLike